Dr Rakesh K Tekade, Assistant Professor of the Department of Pharmaceutics, investigates the design, development and characterization of targeted nanotechnology based formulations for the site specific delivery of therapeutic drugs, siRNA, microRNA, plasmids, proteins and peptide for the treatment of cancer. His current research encompasses development of novel polymeric nanomaterial for effective cytosolic delivery of anticancer bioactives. Dr Tekade’s research is focused on designing a new generation of nanoparticles, which could identify the cancer cells and selectively deliver anticancer drugs and genes to inhibit the growth of cancer while sparing healthy tissues. His research work involves the applications of polymer chemistry, nanotechnology, molecular biology, pharmacokinetics/pharmacodynamics and imaging techniques. Dr Tekade has over 70 publications, 01 patent, 7 book chapters, and 3 editorial articles. He has delivered several invited research talks and presented research finding in more than 30 scientific conferences.

• 1. Design of materials and product specifications2. Biomaterials in Pharmaceutical Product Development: An emphasis on Synthesis and characterization3. Surface modification of Biomaterials towards effective Pharmaceutical Product Development4. Biomaterials for sustained and controlled delivery of small drug molecule5. Biotechnology based pharmaceutical products6. Approaches to development of Implantable therapeutic systems7. Nanotechnology in Tissue Engineering8. Bionanomaterials in the treatment of leishmeniasis9. Recent updates on Nanomedicine based drug delivery approaches in dentistry10. Current research perspectives of Orthopaedic implant materials11. Biomaterials and nanoparticles for hyperthermia therapy12. Hyaluronic acid as an Emerging technology platform for siRNA delivery13. Thiolated-chitosan: a novel mucoadhesive polymer for improved drug delivery14. Recent Advances and Challenges in Microneedle Mediated Transdermal Protein and Peptide Drug Delivery15. Synthesis and Applications of Metal Nanoparticles16. Functionalized carbon nanotubes (CNTs) for protein, peptides and gene delivery biomaterials17. Surface modifications of biomaterials and their implication on biocompatibility

Dr Rakesh K Tekade, Assistant Professor of the Department of Pharmaceutics, investigates the design, development and characterization of targeted nanotechnology based formulations for the site specific delivery of therapeutic drugs, siRNA, microRNA, plasmids, proteins and peptide for the treatment of cancer. His current research encompasses development of novel polymeric nanomaterial for effective cytosolic delivery of anticancer bioactives. Dr Tekade’s research is focused on designing a new generation of nanoparticles, which could identify the cancer cells and selectively deliver anticancer drugs and genes to inhibit the growth of cancer while sparing healthy tissues. His research work involves the applications of polymer chemistry, nanotechnology, molecular biology, pharmacokinetics/pharmacodynamics and imaging techniques. Dr Tekade has over 70 publications, 01 patent, 7 book chapters, and 3 editorial articles. He has delivered several invited research talks and presented research finding in more than 30 scientific conferences.

• 1. Design of materials and product specifications2. Biomaterials in Pharmaceutical Product Development: An emphasis on Synthesis and characterization3. Surface modification of Biomaterials towards effective Pharmaceutical Product Development4. Biomaterials for sustained and controlled delivery of small drug molecule5. Biotechnology based pharmaceutical products6. Approaches to development of Implantable therapeutic systems7. Nanotechnology in Tissue Engineering8. Bionanomaterials in the treatment of leishmeniasis9. Recent updates on Nanomedicine based drug delivery approaches in dentistry10. Current research perspectives of Orthopaedic implant materials11. Biomaterials and nanoparticles for hyperthermia therapy12. Hyaluronic acid as an Emerging technology platform for siRNA delivery13. Thiolated-chitosan: a novel mucoadhesive polymer for improved drug delivery14. Recent Advances and Challenges in Microneedle Mediated Transdermal Protein and Peptide Drug Delivery15. Synthesis and Applications of Metal Nanoparticles16. Functionalized carbon nanotubes (CNTs) for protein, peptides and gene delivery biomaterials17. Surface modifications of biomaterials and their implication on biocompatibility

Dr Rakesh K Tekade, Assistant Professor of the Department of Pharmaceutics, investigates the design, development and characterization of targeted nanotechnology based formulations for the site specific delivery of therapeutic drugs, siRNA, microRNA, plasmids, proteins and peptide for the treatment of cancer. His current research encompasses development of novel polymeric nanomaterial for effective cytosolic delivery of anticancer bioactives. Dr Tekade’s research is focused on designing a new generation of nanoparticles, which could identify the cancer cells and selectively deliver anticancer drugs and genes to inhibit the growth of cancer while sparing healthy tissues. His research work involves the applications of polymer chemistry, nanotechnology, molecular biology, pharmacokinetics/pharmacodynamics and imaging techniques. Dr Tekade has over 70 publications, 01 patent, 7 book chapters, and 3 editorial articles. He has delivered several invited research talks and presented research finding in more than 30 scientific conferences.

• 1. Design of materials and product specifications2. Biomaterials in Pharmaceutical Product Development: An emphasis on Synthesis and characterization3. Surface modification of Biomaterials towards effective Pharmaceutical Product Development4. Biomaterials for sustained and controlled delivery of small drug molecule5. Biotechnology based pharmaceutical products6. Approaches to development of Implantable therapeutic systems7. Nanotechnology in Tissue Engineering8. Bionanomaterials in the treatment of leishmeniasis9. Recent updates on Nanomedicine based drug delivery approaches in dentistry10. Current research perspectives of Orthopaedic implant materials11. Biomaterials and nanoparticles for hyperthermia therapy12. Hyaluronic acid as an Emerging technology platform for siRNA delivery13. Thiolated-chitosan: a novel mucoadhesive polymer for improved drug delivery14. Recent Advances and Challenges in Microneedle Mediated Transdermal Protein and Peptide Drug Delivery15. Synthesis and Applications of Metal Nanoparticles16. Functionalized carbon nanotubes (CNTs) for protein, peptides and gene delivery biomaterials17. Surface modifications of biomaterials and their implication on biocompatibility